Point of Care - Sepsis Study
Key facts
- Who runs it
- Medical University of Graz
- Where
- Austria1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 80 people, planned
- Started
- 13 Aug 2026
- Expected to end
- 31 Aug 2028
- Type of study
- Observational
- Treatments tested
- Point-of-Care Measurement of Inflammatory Biomarkers
- Record updated
- 6 October 2026
Who can take part
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 4 criteriaShow less
Who can take part
- Preterm neonates born at <37+0 weeks of gestation who are admitted to the Division of Neonatology, Department of Pediatrics, Medical University of Graz after birth
- Written parental informed consent before birth
Who cannot take part
- Term and preterm neonates who are not admitted to the neonatal care unit
- No point-of-care measurement of IL-6 and PCT in neonatal blood for infants who do not require blood gas analysis within the first 12 hours of life
This trial is currently available in Austria.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This pilot study will evaluate whether a rapid point-of-care blood test can help identify early signs of infection and sepsis in preterm infants. The study will include preterm infants born before 37 weeks of pregnancy who are admitted to the neonatal care unit and have a suspected infection.
Read full original descriptionShow less
The researchers will measure several substances in the blood that can increase during infection, including interleukin-6 (IL-6), procalcitonin (PCT), C-reactive protein (CRP), and myxovirus resistance protein A (MxA). Results obtained with the point-of-care device will be compared with standard laboratory measurements. The researchers will also study whether measuring IL-6 and PCT during the first 12 hours of life may provide useful information about infection earlier than CRP testing and whether combined MxA and CRP measurements may help distinguish bacterial from viral infections.
This is an observational study and will not change the infants' standard medical care or treatment. Results from the point-of-care device will not be used to make treatment decisions during the study. Blood samples will be collected as part of, or together with, routine blood sampling whenever possible. The study is expected to include approximately 40 preterm infants, with a maximum of 80 infants enrolled.
The group in the trial
- Preterm infants immediately after birth with suspected infection
Preterm infants born at less than 37 weeks of gestation who are admitted to the neonatal care unit and have a clinical suspicion of infection will be enrolled. Participants will receive standard clinical care according to institutional protocols. As part of the study, inflammatory markers (IL-6, PCT, CRP, and MxA) will be measured using a point-of-care device. Selected measurements will be compared with standard laboratory measurements. Cord blood will be used for IL-6 and PCT measurements at birth. When heel blood is obtained for routine clinical testing, additional point-of-care measurements may be performed during the first 36 hours of life. The point-of-care test results will not be used to guide clinical treatment or patient management. Clinical decisions, including antibiotic treatment and additional diagnostic testing, will be based on standard-of-care assessments.
Treatment: Point-of-Care Measurement of Inflammatory Biomarkers
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Diagnostic Accuracy of Inflammatory Parameters for the Diagnosis of Early Onset Neonatal Sepsis and Differentiation Between Viral and Bacterial Infections in Preterm Infants Using a Point-of-care Device - a Pilot Study (POCT Sepsis)
- Record updated
- 6 October 2026